The health and human services secretary is shrinking staff at health agencies and reshaping the mission of his department to ...

The annual meeting of the American Society of Clinical Oncology was held from May 31 to June 3 in Chicago and hosted more ...

ASCO 2025 delivered pivotal updates. In this article, we discuss 8 of the more interesting abstracts from an investment ...

Some men might also inherit a family cancer syndrome that increases their cancer risk. For instance, Lynch syndrome can put ...

ASCO Data Shows New Therapy Delays Breast Cancer Progression and May Improve Quality of Life for Women with Hormone ...

Dietmar Berger, M.D., Ph.D., joined Gilead Sciences as chief medical of | Dietmar Berger became Gilead Sciences’ new chief ...

One study looked at over 900 colon cancer patients, and it found around 28% reduction in the risk of recurrence or new cancer ...

Patient with a grade 4, IDH-mutant, MGMT-methylated glioma remains alive and progression-free for four years after receiving ...

After two years of quietly shifting its medical affairs and commercial strategy units under one roof, Astellas is entering a ...

MEDSIR announces positive results from TUXEDO-3 trial of patritumab deruxtecan in patients with active brain metastases and leptomeningeal disease: Chicago Monday, June 9, 2025, 1 ...

Chinese shares trading in Hong Kong entered a bull market on Monday, as planned talks between the US and China fueled a wider ...

The U.S. Food and Drug Administration has granted de novo authorization to CLAIRITY BREAST, a first-in-class, image-based ...